At a glance
ClinicalIndex Comparison RecordN/ACompleted· 24 enrolled
Drug / intervention
eszopiclone +1 moredrug
Likely dose
eszopiclone 3mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Daytime Eszopiclone Administration in Shift Workers on Overnight Wakefulness During a Subsequent Simulated Nightshift
In Brief
A clinical study evaluating eszopiclone and matching placebo for Shift-Work Sleep Disorder. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The purpose of this study is to test the effects of eszopiclone on daytime sleep and overnight wakefulness in shift workers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsShift-Work Sleep Disorder
CountriesUnited States
CollaboratorsSumitomo Pharma America, Inc., Massachusetts General Hospital
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2009
First PostedMay 2009
Primary CompletionJan 2010
Study CompletionFeb 2010
TodayJul 2026
First PostedMay 12, 2009
Enrollment StartMay 1, 2009
Primary CompletionJan 1, 2010
Study CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 17.1 years ago
Interventions
eszopiclonedrug
3mg eszopiclone prior to daytime sleep for 3 days (at home) and 1 day (in lab)
matching placebodrug
matching placebo prior to daytime sleep for 3 days (at home) and 1 day (in lab)